Amphastar's Q3 Beats Estimates, Shares Plummet

Amphastar Pharmaceuticals exceeded earnings expectations in Q3, reporting a profit of $17.4 million or $0.37 per share, and $0.93 per share adjusted. Revenue also surged to $191.8 million. However, shares have plummeted 55% over the last year, despite the positive earnings report, reflecting the volatile nature of the pharmaceutical market.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.